+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Iron-mobilizing properties of the gadolinium-DTPA complex: clinical and experimental observations

Iron-mobilizing properties of the gadolinium-DTPA complex: clinical and experimental observations

Nephrology, Dialysis, Transplantation 18(5): 884-887

Background. Gadolinium (Gd) magnetic resonance imaging (MRI) contrast agents are considered to be safe in patients with impaired renal function. Our study investigates a mechanism of severe iron intoxication with life-threatening serum iron levels in a haemodialysis patient following MRI with Gd-diethylenetriaminepentaacetic acid (Gd-DTPA) administration. His previous history was remarkable for multiple blood transfusions and biochemical evidence of iron overload. We hypothesized that Gd-DTPA may have an iron-mobilizing effect in specific conditions of iron overload combined with prolonged exposure to the agent. Methods. For the in vitro study, Gd-DTPA was added to mice liver homogenate and iron metabolism parameters were measured after incubation in comparison with the same samples incubated with saline only. For the in vivo study, an experimental model of acute renal failure in iron-overloaded rats was designed. Previously iron-overloaded and normally fed rats underwent bilateral nephrectomy by renal pedicle ligation, followed by Gd-DTPA or saline injection. Iron and iron saturation levels were checked before and 24 h after Gd-DTPA or vehicle administration. Results. Significant mobilization of iron from mice liver tissue homogenate in mixtures with Gd in vitro was seen in the control (saline) and in the experimental (Gd) groups (513 +- 99.1 vs 1117.8 +- 360.8 mug/dl, respectively; P < 0.05). Administration of Gd-DTPA to iron-overloaded rats after renal pedicle ligation caused marked elevation of serum iron from baseline 143 +- 3.4 to 570 +- 8 mug/dl (P < 0.0001). There were no changes of the named parameter, either in iron-overloaded anuric rats after saline injection or in normal diet uraemic animals, following Gd-DTPA administration. Conclusions. The combination of iron overload and lack of adequate clearance of Gd chelates may cause massive liberation of iron with dangerous elevation of free serum iron. It is highly recommended that after Gd contrast study, end-stage renal disease patients with probable iron overload should undergo prompt and intensive haemodialysis for prevention of this serious complication.

(PDF emailed within 0-6 h: $19.90)

Accession: 010885544

Download citation: RISBibTeXText

PMID: 12686659

DOI: 10.1093/ndt/gfg064

Related references

Dynamic contrast-enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutrol, gadolinium-DTPA-polylysine, and gadolinium-DTPA-cascade-polymer. Magnetic Resonance in Medicine 32(5): 622-628, 1994

Mr image time intensity relations in spleen and kidney a comparative study of gadolinium dtpa albumin gadolinium dtpa and gadolinium oxide colloid. American Journal of Physiologic Imaging 5(3): 119-124, 1990

Some physicochemical properties of the gadolinium-DTPA complex, a contrast agent for MRI. Physiological Chemistry and Physics and Medical Nmr 16(2): 105-112, 1984

Experimental studies on nmr contrast enhancing agent gadolinium dtpa complex. Journal of Shanghai Medical University 19(1): 67-72, 1992

A pharmacokinetic and mri study of unilamellar gadolinium dtpa stearate manganese dtpa stearate and iron dtpa stearate liposomes as organ specific contrast agents. Investigative Radiology 25(8): 922-932, 1990

Pharmacokinetic analysis of blood distribution of intravenously administered gadolinium 153 labeled gadolinium dtpa and technetium 99m dtpa in rats. Magnetic Resonance Imaging 8(5): 567-576, 1990

Comparison of initial biodistribution patterns of gadolinium dtpa and albumin gadolinium dtpa using rapid spin echo mr imaging. Journal of Computer Assisted Tomography 11(2): 306-313, 1987

Comparison of gadolinium-DTPA and macromolecular gadolinium-DTPA-polylysine for contrast-enhanced pulmonary time-of-flight magnetic resonance angiography. Investigative Radiology 31(10): 652-657, 1996

Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat. Investigative Radiology 30(10): 572-581, 1995

Comparison of the biodistribution of gadolinium 153 labeled chelates of gadolinium dtpa gadolinium dota and gadolinium acetate n in mice. Nuclear Medicine & Biology 15(4): 395-402, 1988

Magnetic resonance imaging using nmr contrast agent gadolinium labeled monoclonal antibodies gadolinium dtpa mab 733 and 199 directed against crc human tumor and gadolinium dtpa mab oc 125 directed against human ovarian tumor. Nuclear Medicine & Biology 16(2): 180, 1989

Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil. Investigative Radiology 29 Suppl 2: S245-S246, 1994

Gadolinium-DTPA enhanced echoplanar MR imaging of the liver: preliminary observations. Clinical Radiology 51(8): 545-549, 1996

Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. Ajr. American Journal of Roentgenology 142(3): 619-624, 1984